Special Issue "Natural Products against Viral Infections II"
Deadline for manuscript submissions: closed (31 August 2020) | Viewed by 27880
Interests: natural product drug discovery; essential oils; chemical ecology; molecular modeling
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Molecular Sciences: Natural Products against Viral Infections
Special Issue in Biomolecules: Plant-Food-Derived Bioactive Molecules on Human Longevity and Disease Prevention
Special Issue in Molecules: Phytochemistry, Biological Activities and Applications of the Piperaceae
Special Issue in International Journal of Molecular Sciences: Cannabis: Chemical Compositions and Molecular Pharmacology
Special Issue in Antibiotics: Antimicrobial Activity of Higher Plants
Special Issue in Molecules: Pure and Natural Herbal Medicines and Essential Oils: Authentication and Detection of Adulteration and Contamination
Special Issue in Molecules: 50th Anniversary Issue of Artemisinin: The Successful Use of Natural Products against Parasitic Agents
Special Issue in Antibiotics: 10th Anniversary of Antibiotics—Recent Advances in Plant-Derived Antibiotics
Special Issue in Plants: Phytochemistry of Aromatic and Medicinal Plants
Topics: Natural Compounds in Plants
Although immunization against viral infections has reduced or eradicated several viral diseases, including smallpox, polio, and measles, viral infections continue to be a source of human morbidity and mortality. Antiviral drug resistance has been emerging, and viral mutations present new problems for treatment of viral infections. Thus, for example, acyclovir- and penciclovir-resistant strains of HSV-1 and HSV-2 are emerging, several HIV mutants have shown resistance to reverse transcriptase inhibitors, and there are constant mutations in influenza viruses. In addition, emerging viral infectious diseases, such as severe acute respiratory syndrome (SARS), Chikungunya virus, West Nile virus, and Zika virus, are presenting new challenges. Natural products have been and will continue to be excellent sources of medicinal agents. This Special Issue is directed at natural product drug discovery of antiviral agents. We welcome contributions directed at in vitro and in vivo screening of extracts and natural products against viruses, as well as in silico efforts at antiviral drug discovery. Both original research papers and timely reviews are welcome.
Prof. Dr. William N. Setzer
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Natural products
- Drug discovery
- Antiviral agents
- In vitro screening
- In vivo screening
- In silico screening
- Antiviral drug targets
- Emerging viral diseases